NCT00476515View on ClinicalTrials.gov

Rituximab Therapy for Patients on Kidney Transplant Waiting List With Positive Donor Specific Crossmatch to Living Donor

PHASE1WithdrawnINTERVENTIONAL

0

Timeline

Start Date

March 31, 2007

Primary Completion Date

September 30, 2007

Study Completion Date

September 30, 2007

Conditions

Kidney Insufficiency

Interventions

DRUG

Rituximab

the recommended dosage of Rituximab is 375 mg/m2 given as an IV infusion once weekly for four doses (days 1, 8, 15, and 22).

Sponsors

Collaborators (2)

Genentech, Inc.

All Listed Sponsors

collaborator

Biogen

INDUSTRY

collaborator

Genentech, Inc.

INDUSTRY

lead

Massachusetts General Hospital

OTHER